Muscle Weakness
Conditions
Interventions
A prospective, randomized, controlled study will be carried out with a total sample of 60 patients, for an annual population of approximately 600 patients admitted to each ICU, we estimate a margin of
Sponsors
Universidade Estadual do Piauí - UESPI
Universidade Estadual do Piauí - UESPI
Eligibility
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Adults over 18 years old. Both genders. Hospitalization for more than 24 hours in the ICU ward. The stay must be at least 72 hours
Exclusion criteria
Exclusion criteria: Neuromuscular pathology. Osteoarticular contraindication to mobilization. Amputees. Pregnant women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of acquired muscle weakness in critical patients; as well as the identification of the role of blood flow restriction therapy in preventing muscle weakness in critical patients. | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of the safety and feasibility of blood flow restriction therapy in critical patients, thus contributing to the production of scientific evidence in the field of early mobilization in critical patients. | — |
Countries
Brazil
Contacts
Public ContactGabriel Barros
Universidade Estadual do Piauí - UESPI
Outcome results
None listed